Identification of musashi-1 and ALDH1 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma
Identification of musashi-1 and ALDH1 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma
复制标题
DOI:
10.3233/dma-2011-0812
复制
发表时间:
2010-01-01
影响因子:
3.1
通讯作者:
Jiang, Song
中科院分区:
文献类型:
--
作者:
Liu, Dong-Cai;Yang, Zhu-Lin;Jiang, Song
In this study, we investigated the expressions of Msi-1 and ALDH1 in gallbladder adenocarcinoma (n = 100), peritumoral tissues (n = 46), adenomatous polyp (n = 15), and chronic cholecystitis (n = 35) using immunohistochemical method. The percentage of cases with positive Msi-1 and ALDH1 expression were significantly higher in gallbladder adenocarcinoma than that in peritumoral tissues, adenomatous polyp and chronic cholecystitis (ps < 0.01). The expression of Msi-1 and ALDH1 was significantly associated with differentiation, tumor mass, lymph node metastasis and invasion of adenocarcinoma. The expression of Msi-1 and ALDH1 was found to be highly consistent in gallbladder adenocarcinoma (p < 0.01). Univariate Kaplan-Meier analysis showed a negative correlation between Msi-1 (p = 0.042) or ALDH1 (p < 0.001) expression with overall survival. The average survival time of patients with both low or no Msi-1 expression and ALDH1 expression was significantly longer than patients with the other three subtypes (p < 0.001). Multivariate Cox regression analysis showed that positive expression of Msi-1 or ALDH1 (p = 0.016, p = 0.006, respectively) was an independent bad-prognostic predictor in gallbladder adenocarcinoma. Our study suggested that Msi-1 and/or ALDH1 expression might be closely related to the carcinogenesis, progression, clinical biological behaviors, and prognosis of gallbladder adenocarcinoma.